Connecticut Wealth Management’s TriSalus Life Sciences TLSI Stock Holding History

Connecticut Wealth Management’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89.2K	Hold	22,303	–	–	﹤0.01%	327
2025 Q4	$156K	Hold	22,303	–	–	0.01%	315
2025 Q3	$104K	Hold	22,303	–	–	﹤0.01%	317
2025 Q2	$122K	Hold	22,303	–	–	0.01%	308
2025 Q1	$123K	Hold	22,303	–	–	0.01%	301
2024 Q4	$112K	Sell	22,303 -10,576	-32%	-$44.7K	0.01%	266
2024 Q3	$152K	Hold	32,879	–	–	0.01%	323
2024 Q2	$181K	Sell	32,879 -11,727	-26%	-$99.5K	0.01%	317
2024 Q1	$435K	Sell	44,606 -12,582	-22%	-$116K	0.02%	226
2023 Q4	$483K	Hold	57,188	–	–	0.03%	213
2023 Q3	$293K	Buy	+57,188	New	+$468K	0.02%	233

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Connecticut Wealth Management's TLSI Position: Q1 2026 in Review

Connecticut Wealth Management held its TriSalus Life Sciences (TLSI) position steady in Q1 2026 at 22,303 shares worth $89.2K. The position accounts for ﹤0.01% of the portfolio, ranked #327.

Connecticut Wealth Management first reported a position in TLSI in Q3 2023 and has held it in 11 quarters since. The position peaked at $483K in Q4 2023. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

Connecticut Wealth Management held 22,303 shares of TriSalus Life Sciences worth $89.2K as of Q1 2026.
Connecticut Wealth Management left its TriSalus Life Sciences share count unchanged in Q1 2026.
TriSalus Life Sciences made up ﹤0.01% of Connecticut Wealth Management's portfolio in Q1 2026, its #327 holding.
Connecticut Wealth Management first reported a position in TriSalus Life Sciences in Q3 2023 and has held it in 11 quarters since.
Connecticut Wealth Management's TriSalus Life Sciences position peaked at $483K in Q4 2023.
84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Connecticut Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.